Shield Thera Share Price (STX)

Just look at the last two fundraises - £15.1m in December 2022 and then £5.1m + £16m ($20m) debt facility - and compare it with today's mcap. We know full well from the misses that another funding round is going to be needed and now they have debt to service and are well short of break even they aren't going to access further debt financing so it's got to come via equity.

Raising just £10m this time around will double the shares in issue, add an extra 50% for another £5m.

This isn't investable until (i) financing has been arranged and (ii) there's a clear improvement seen that gives confidence to profitability being achievable.

Thank you all for your responses.

Did anyone try to get management to do Q&A with the investors ?

Also what about AGM ? Are the resolutions being approved when everyone is so unhappy?

As time has gone on here, it simply gets harder to 'just' put this down to useless corporate mismanagement. Just too many things that simply do not make sense.

Some of my earlier comments here outline what I think is going to be the end game here now.

None of them lead to a positive result for the majority of shareholders.

More recently, I have wondered if we might see an ETX or C4DX type of outcome, although I think the odds remain greater that AOP will simply issue the company with another loan, on ruinous terms that essentially might as well mean a wipe out for ordinary shareholders.

To be announced whenever we get the next update. Which will be full of the same BS as all the other ones probably.

Or maybe at best eg a 1p all share cash offer. Why would they pay more than they need to?

Ultimately, if they were unhappy with the CEO and wider management team, they would have been in a position to do something about it a long time ago. Something to ponder.

But others may hold different opinions and that is fine too. GLA. Except the BOD.

Lwhl,

Fully agree, shocking management and I do wonder has it been taken this way deliberately. The silence is shocking.

All the promises followed by continual inaction and failure at every turn.

FDA approval was not cheap (any idea of the cost)....but this company will be stolen by AOP at a cheap price or put into administration & bought out in a pre packed deal.

All IMHO, dyor

Riz,

The leaders in this company have failed to tell us who the 3rd party is they blame for what is a shambles. How can your revise down your forecasts and still miss it by 40+% and blame someone else.

No director has bought at these low low prices but then again that could be viewed as a slap in the teeth to us holding at a much higher price. I have a few cronies who will by big into this if it starts to move. But the path must be a lot clearer and I don't think those in charge have the capabilities for clearing a path.

How much of the funding have they burnt through? No one knows as they tell us paupers very little.